Assessing unipolar mood disorders in women

Psychopharmacology Bulletin

Volumn 34, Issue 3, 1998, Pages 261-266

  Yonkers, Kimberly A ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Depression; Dysthymic disorder; PMS; Postpartum depression; Sex factors

Indexed keywords

AFFECTIVE NEUROSIS; CONFERENCE PAPER; DYSPHORIA; DYSTHYMIA; FEMALE; HUMAN; MALE; MEDICAL RESEARCH; MENTAL HEALTH; MOOD; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; PSYCHOLOGIC TEST; SEX DIFFERENCE;

FEMALE; HUMANS; MOOD DISORDERS; WOMEN;

EID: 0031763329     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (68)

1. Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Service. Depression in Primary Care: Volume 1. Detection and Diagnosis. Clinical Practice Guideline, Number 5. AHCPR Pub. No. 93-0551. Rockville, MD: AHCPR, April 1993.
2. American Psychiatric Association. DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders. 3rd ed, revised. Washington, DC: American Psychiatric Association, 1987.
3. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
4. Appleby, L; Warner, R; Whitton, A; and Faragher, B. A controlled study of fluoxetine and cognitive-behavioral counseling in the treatment of postnatal depression. Br. Med. J. 314:932-936, 1997.
5. Ballard, CG; Davis, R; Cullen, PC; Mohan, RN; and Dean, C. Prevalence of postnatal psychiatric morbidity in mothers and fathers. Br. J. Psychiatry 164:782-788, 1994.
6. Bifulco, A; Brown, GW; and Adler, Z. Early sexual abuse and clinical depression in adult life. Br. J. Psychiatry 159:115-122, 1991.
7. Brown, GW; Adler, Z; and Bifulco, A. Life events, difficulties and recovery from chronic depression. Br. J. Psychiatry 152:487-498, 1988.
8. Brown, GW, and Harris, TO. Social Origins of Depression: A Study of Psychiatric Disorder in Women. 1st ed. Vol. 1. New York: Free Press, 1978.
9. Cox, JL; Murray, D; and Chapman, G. A controlled study of the onset, duration and prevalence of postnatal depression. Br. J. Psychiatry 163:27-31, 1993.
10. Endicott, J; Halbreich, U; Schacht, S; and Nee, J. Premenstrual changes and affective disorders. Psychosom. Med. 43(6):519-529, 1981.
11. Eriksson, E; Hedberg, MA; Andersch, B; and Sundblad, C. The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology 12(2): 169-176, 1995.
12. Field, T; Healy, B; Goldstein, S; Perry, S; Bendell, D; Schanberg, S; Zimmerman, EA; and Kuhn, C. Infants of depressed mothers show "depressed" behavior even with nondepressed adults. Child Dev. 59:1569-1579, 1988.
13. Graze, KK; Nee, J; and Endicott, J. Premenstrual depression predicts future major depressive disorder. Acta Psychiatr. Scand. 81:201-205, 1990.
14. Greenberg, PE; Stiglin, LE; Finkelstein, SN; and Berndt, ER. The economic burden of depression in 1990. J. Clin. Psychiatry 54(11):405-418, 1993.
15. Gregoire, AJP; Kumar, R; Everitt, B; Henderson, AF, and Studd, JWW. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 347:930-933, 1996.
16. Halbreich, U, and Endicott, J. Relationship of dysphoric premenstrual changes to depressive disorder. Acta Psychiatr. Scand. 71:331-338, 1985.
17. Halbreich, U; Endicott, J; Goldstein, S; and Nee, J. Premenstrual changes and changes in gonadal hormones. Acta Psychiatr. Scand. 74:576-586, 1986
18. Halbreich, U, and Lumley, LA. The multiple interactional biological processes that might lead to depression and gender differences in its appearance. J. Affect. Disord. 29:159-173, 1993.
19. Halbreich, U; Petty, F; Yonkers, K; Kramer, GL; Rush, AJ; and Bibi, KW. Low plasma γ-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder. Am. J. Psychiatry 153(5):718-720, 1996.
20. Halbreich, U; Rojansky, N; Zander, KJ; and Barkai, A. Influence of age, sex and diurnal variability on imipramine receptor binding and serotonin uptake in platelets of normal subjects. J. Psychiatr. Res. 25(1/2):7-18, 1991.
21. Halbreich, U, and Smoller, JW. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome. J. Clin. Psychiatry 58:1-4, 1997.
22. Halbreich, U, and Tworek, H. Altered serotonergic activity in women with dysphoric premenstrual syndromes. Int. J. Psychiatry Med. 23:1-27, 1993.
23. Hamilton, JA; Grant, M; and Jensvold, MF. Sex and Treatment of Depressions. When Does it Matter? In: Jensvold, MF; Halbreich, U; and Hamilton, JA, eds. Psychopharmacology and Women. Sex, Gender, and Hormones. Washington, DC: American Psychiatric Press, Inc., 1996. pp. 241-260.
24. Hamilton, J, and Parry, B. Sex-related differences in clinical drug response: Implications for women's health. JAMA 38(5):126-131, 1983.
25. Hay, DF, and Kumar, R. Interpreting the effects of mothers' postnatal depression on children's intelligence: A critique and re-analysis. Child Psychiatry Hum. Dev. 25(3):165-181, 1995.
26. Hays, RD; Wells, KB; Sherbourne, CD; Rogers, W; and Spritzer, K. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch. Gen. Psychiatry 52:11-19, 1995.
27. Keller, MB; Harrison, W; Fawcett, JA; Gelenberg, A; Hirschfeld, RMA; Klein, D; Kocsis, JH; McCullough, JP; Rush, AJ; Schatzberg, A; and Thase, ME. Mood Disorders. Treatment of chronic depression with sertraline or imipramine: Preliminary blinded response rates and high rates of undertreatment in the community. Psychopharmacol. Bull. 31(2):205-212, 1995.
28. Keller, MB; Klerman, GL; Lavori, PW; Fawcett, JA; Coryell, W; and Endicott, J. Treatment received by depressed patients. JAMA 248:1848-1855, 1982.
29. Keller, MB; Lavori, PW; Klerman, GW; Andreasen, NC; Endicott, J; Coryell, W; Fawcett, J; Rice, JP; and Hirschfeld, RMA. Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients. Arch. Gen. Psychiatry 43:458-466, 1986.
30. Kendell, RE; Chalmers, JC; and Platz, C. Epidemiology of puerperal psychoses. Br. J. Psychiatry 150:662-673, 1987.
31. Kessler, RC; McGonagle, KA; Zhao, S; Nelson, CB; Hughes, M; Eshleman, S; Wittchen, HU; and Kendler, KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 51:8-19, 1994.
32. Kessler, RG; Rubinow, DR; Holes, C; Abelson, JM; and Zhao, S. The epidemiology of euphoric-grandiose DSM-III-R bipolar I disorder in a general population survey. Submitted for publication.
33. Leibenluft, E. Women with bipolar illness: Clinical and research issues. Am. J. Psychiatry 153(2):163-173, 1996.
34. McCormack, HM; Horne, DJ; and Sheather, S. Clinical applications of visual analogue scales: A critical review. Psychol. Med. 18:1007-1019, 1988.
35. Miller, JB, and Stiver, I. A relational approach to understanding women's lives and problems. Psychiatr. Ann. 23:424-431, 1993.
36. Murray, L. The impact of postnatal depression on infant development. J. Child Psychol. Psychiatry 33(3):543-561, 1992.
37. O'Hara, MW. Postpartum Mental Disorders. In: Sciarra, JJ, ed. Gynecology and Obstetrics. 1st ed. Vol. 6. Philadelphia, PA: Harper & Row, 1991. pp. 1-17.
38. O'Hara, MW; Zekoski, EM; Philipps, LH; and Wright, EJ. Controlled prospective study of postpartum mood disorders: Comparison of childbearing and nonchildbearing women. J. Abnorm. Psychol. 99(1):3-15, 1990.
39. Pearlstein, TB; Stone, AB; Lund, SA; Scheft, H; Zlotnick, C; and Brown, WA. "A double-blind comparison of fluoxetine, buproprion and placebo in premenstrual dysphoric disorder." Abstract # NR314. Presented at the Annual Meeting for the American Psychiatric Association, Miami, FL, 1995.
40. Pearlstein, TB; Stone, AB; Lund, SA; Scheft, H; Zlotnick, C; and Brown, WA. Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder. J. Clin. Psychopharmacol. 17(4):261-266, 1997.
41. Pop, VJM; Essed, GGM; De Geus, CA; van Son,M; and Komproe, IH. Prevalence of post partum depression - or is it post-puerperium depression? Acta Obstet. Gynecol. Scand. 72:354-358, 1993.
42. Rivera-Tovar, AD, and Frank, E. Late luteal phase dysphoric disorder in young women. Am. J. Psychiatry 147(12):1634-1636, 1990.
43. Rojansky, N; Halbreich, U; Zander, K; Barkai, A; and Goldstein, S. Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes. Gynecol. Obstet. Invest. 31:146-152, 1991.
44. Rush, AJ; Golden, WE; Hall, GW; Herrera, CM; Houstoh, A; Kathol, RG; Katon, W; Matchett, CL; Petty, F; Schulberg, HC; Smith, GR; and Stuart, GW, eds. Depression in Primary Care: Vol. 2. Treatment of Major Depression. Clinical Practice Guideline Number 5. AHCPR Pub. No. 93-0551. Rockville, MD: Agency for Health Care Policy and Research, April 1993.
45. Rush, AJ; Gullion, CM; Basco, MR; Jarrett, RB; and Trivedi, MH. The Inventory of Depressive Symptomatology (IDS) psychometric properties. Psychol. Med. 26:477-486, 1996.
46. Sherbourne, CD; Wells, KB; Hays, RD; Rogers, W; Burnam, A; and Judd, LL. Subthreshold depression and depressive disorder: Clinical characteristics of general medical and mental health specialty outpatients. Am. J. Psychiatry 151:1777-1784, 1994.
47. Spitzer, RL; Kroenke, K; Linzer, M; Hahn, SR; Williams, JBW; DeGruy, FV, III; Brody, D; and Davies, M. Health related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 study. JAMA 274(19):1511-1517, 1995.
48. Steiner, M. Psychobiology of mental disorders associated with child-bearing. An overview. Acta Psychiatr. Scand. 60(5):449-464, 1979.
49. Steiner, M. The effects of gonadal hormones on brain and behavior. Prog. Neuropsychophamacol. Biol. Psychiatry 11:115-119, 1987.
50. Steiner, M, and Carroll, BJ. The psychobiology of premenstrual dysphoria: Review of theories and treatments. Psychoneuroendocrinology 2:321-335, 1977.
51. Steiner, M; Korzekwa, M; Lamont, J; and Wilkins, A. Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria. Psychopharmacol. Bull. 33(4):771-774, 1997.
52. Steiner, M, and Kumar, R. Serotonin reuptake inhibitors in the treatment of premenstrual dysphoria: Current state of knowledge. J. Psychiatry Clin. Pract., in press.
53. Steiner, M; Wheadon, D; Kreider, M; and Bushnell, W. Antidepressant response to paroxetine by gender (Abstract #462). Presented at the Annual Meeting of the American Psychiatric Association, San Francisco, CA, May 1993.
54. Sturm, R, and Wells, KB. How can care for depression become more cost effective. JAMA 273:51-58, 1995.
55. Wang, M; Seippel, L; Purdy, RH; and Backstrom, T. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: Study on serum pregnenolone, pregnenolone sulfate, 5a-pregnane-3, 20-dione and 3a-hydroxy-5a-pregnan-20-one. J. Clin. Endocrinol. Metab. 81:1076-1082, 1996.
56. Wang, MD; Landgren, S; and Backstrom, T. Rapid communication. The effects of allopregnanolone, pregnenolone sulphate and pregnenolone on the CA1 population spike of the rat hippocampus after 17B-oestradiol priming. Acta Physiol. Scand. 159:343-344, 1997.
57. Weissman, MM; Bland, RC; Canino, GJ; Faravelli, C; Greenwald, S; Hwu, H-G; Joyce, PR; Karam, EG; Lee, C-K; Lellouch, J; Lepine, J-P; Newman, SC; Rubio-Stipec, M; Wells, JE; Wickramaratne, PJ; Wittchen, H-U; and Yeh, E-K. Cross-National Epidemiology of major depression and bipolar disorder. JAMA 276:293-299, 1996.
58. Weissman, MM, and Bothwell, S. Assessment of social adjustment by patient self-report. Arch. Gen. Psychiatry 33:1111-1115, 1976.
59. Weissman, MM; Prusoff, BA; Thompson, WD; Harding, PS; and Myers, J. Social adjustment by self-report in a community sample and in psychiatric outpatients. J. Nerv. Ment. Dis. 166:317-326, 1978.
60. Whiffen, VE. Is postpartum depression a distinct diagnosis? Clin. Psychol. Rev. 12:485-508, 1992.
61. Wieck, A. Endocrine aspects of postnatal mental disorders. Baillieres Clin. Obstet. Gynaecol. 3(4):857-877, 1989.
62. Wieck, A; Kumar, R; Hirst, AD; Marks, MN; Campbell, IC; and Checkley, SA. Increased sensitivity of dopamine receptors and recurrence of affective psychosis after childbirth. Br. Med. J. 303:613-616, 1991.
63. Woods, NF; Most, A; and Dery, GK. Prevalence of perimenstrual symptoms. Am. J. Public Health 72(11):1257-1264, 1982.
64. Yonkers, KA. Treatment of premenstrual dysphoric disorder. Curr. Rev. Mood Anx. Disord. 1(3):215-237, 1997.
65. Yonkers, KA, and Brown, WA. Pharmacologic treatments for premenstrual dysphoric disorder. Psychiatr. Ann. 26(9):1-4, 1996.
66. Yonkers, KA; Clark, RH; and Trivedi, MH. The psychopharmacological treatment of non-major mood disorders. In: Rush, AJ, ed. Mood Disorders: Systematic Medication Management. Modern Problems of Pharmacopsychiatry. Vol. 25: Basel, Switzerland: S. Karger AG, 1996.
67. Yonkers, KA, and Hamilton, JA. Sex differences in pharmacokinetics of psychotropic medications. Part II: Effects on selected psychotropics. In: Jensvold, MJ; Halbreich, U; and Hamilton, JA, eds. Psychopharmacology of Women: Sex, Gender and Hormonal Considerations. 1st ed. Vol. 1. Washington, DC: American Psychiatric Association, 1995.
68. Yonkers, KA; Kando, JC; Cole, JO; and Blumenthal, S. Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. Am. J. Psychiatry 149:587-595, 1992.